Share Price and Basic Stock Data
Last Updated: February 14, 2026, 8:26 pm
| PEG Ratio | 0.81 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Balmer Lawrie & Company Ltd, operating in the diversified industry, reported a revenue of ₹2,312 Cr for the fiscal year ending March 2023, a notable increase from ₹2,051 Cr in the previous year. The company’s sales have shown a consistent upward trajectory, with quarterly sales standing at ₹551 Cr in September 2022 and reaching ₹586 Cr by September 2023. This reflects the company’s robust operational strategies and ability to adapt to market demands. The trailing twelve months (TTM) revenue is recorded at ₹2,555 Cr, indicating a steady growth trend. The operating profit margin (OPM) improved to 12% for the financial year ending March 2025, up from 9% in March 2023, highlighting operational efficiency. Furthermore, the company’s ability to maintain sales growth during challenging economic conditions showcases its resilience and market positioning.
Profitability and Efficiency Metrics
Balmer Lawrie’s profitability metrics indicate a strong performance, with a net profit of ₹258 Cr reported for the latest fiscal year. The company achieved a return on equity (ROE) of 14.0% and a return on capital employed (ROCE) of 14.8%, both of which are commendable figures compared to typical sector averages. The interest coverage ratio (ICR) stood at 13.67x, suggesting that the company comfortably manages its debt obligations. Additionally, the net profit margin rose to 7.74% for March 2025, reflecting improved cost management and pricing strategies. The cash conversion cycle was reported at 33 days, indicating efficient working capital management. Overall, these metrics position Balmer Lawrie favorably within the diversified sector, demonstrating its ability to convert sales into profits effectively.
Balance Sheet Strength and Financial Ratios
Balmer Lawrie’s balance sheet remains robust, with total assets reported at ₹3,040 Cr as of March 2025. The company has maintained a low long-term debt-to-equity ratio of 0.03, indicating prudent financial management and minimal reliance on debt financing. Reserves have increased to ₹1,798 Cr, providing a cushion for future investments and stability. The price-to-book value (P/BV) ratio is at 1.60x, suggesting that the market values the company slightly above its book value, which is typical for well-performing firms in the sector. The current ratio stands at 2.27, demonstrating strong liquidity and the ability to cover short-term liabilities. These financial ratios reflect a solid foundation for continued growth and operational flexibility.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Balmer Lawrie indicates a high level of public ownership at 95.94%, with institutional investors holding a modest share (FIIs at 2.26% and DIIs at 1.79%). This broad public ownership reflects strong retail investor confidence in the company’s performance and governance. The number of shareholders increased to 1,11,490, highlighting growing interest and participation from individual investors. While the foreign institutional investment (FII) has shown a slight fluctuation, increasing from 1.31% in December 2022 to 2.26% by September 2025, this indicates a cautious but positive outlook from international investors. The company’s consistent dividend payout ratio of 55% for March 2025 reinforces its commitment to returning value to shareholders, further bolstering investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Balmer Lawrie’s growth prospects appear promising, bolstered by its strong financial performance and operational efficiency. However, risks such as fluctuating raw material costs and economic uncertainties could impact profitability. The company must also navigate competitive pressures within the diversified sector, which may affect market share. Despite these challenges, its low debt levels and significant reserves provide a buffer against potential downturns. Should the company continue to innovate and adapt to market trends, it could capitalize on growth opportunities. However, if external economic conditions worsen, it may face headwinds that could hinder its progress. Overall, Balmer Lawrie is well-positioned to leverage its strengths while addressing inherent risks in the market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 8,364 Cr. | 1,187 | 1,639/842 | 20.5 | 397 | 0.55 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 17,378 Cr. | 1,114 | 1,502/903 | 24.9 | 463 | 0.81 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 3,035 Cr. | 177 | 238/147 | 11.4 | 114 | 4.79 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 39,575 Cr. | 35,115 | 38,300/25,714 | 64.7 | 1,906 | 0.46 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 17,088.00 Cr | 9,398.25 | 30.38 | 720.00 | 1.65% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 551 | 514 | 608 | 592 | 586 | 585 | 577 | 638 | 639 | 630 | 608 | 681 | 635 |
| Expenses | 513 | 464 | 556 | 528 | 511 | 511 | 485 | 574 | 569 | 546 | 514 | 597 | 568 |
| Operating Profit | 39 | 50 | 52 | 65 | 75 | 74 | 91 | 64 | 70 | 84 | 95 | 83 | 67 |
| OPM % | 7% | 10% | 9% | 11% | 13% | 13% | 16% | 10% | 11% | 13% | 16% | 12% | 11% |
| Other Income | 8 | 3 | 17 | 10 | 13 | 11 | 18 | 12 | 11 | 9 | 18 | 9 | 11 |
| Interest | 4 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 9 | 6 | 7 | 7 |
| Depreciation | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 14 | 14 | 15 | 16 | 14 | 16 |
| Profit before tax | 29 | 34 | 51 | 54 | 69 | 64 | 88 | 56 | 62 | 68 | 90 | 71 | 55 |
| Tax % | 37% | 29% | 51% | 22% | 31% | 24% | 31% | 20% | 30% | 29% | 35% | 27% | 31% |
| Net Profit | 34 | 35 | 43 | 56 | 63 | 66 | 73 | 63 | 61 | 62 | 74 | 67 | 55 |
| EPS in Rs | 2.05 | 2.11 | 2.61 | 3.35 | 3.73 | 3.90 | 4.31 | 3.73 | 3.66 | 3.77 | 4.39 | 4.03 | 3.31 |
Last Updated: January 2, 2026, 8:01 am
Below is a detailed analysis of the quarterly data for Balmer Lawrie & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 635.00 Cr.. The value appears to be declining and may need further review. It has decreased from 681.00 Cr. (Jun 2025) to 635.00 Cr., marking a decrease of 46.00 Cr..
- For Expenses, as of Sep 2025, the value is 568.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 597.00 Cr. (Jun 2025) to 568.00 Cr., marking a decrease of 29.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Jun 2025) to 67.00 Cr., marking a decrease of 16.00 Cr..
- For OPM %, as of Sep 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Jun 2025) to 11.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Jun 2025) to 11.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 7.00 Cr..
- For Depreciation, as of Sep 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 71.00 Cr. (Jun 2025) to 55.00 Cr., marking a decrease of 16.00 Cr..
- For Tax %, as of Sep 2025, the value is 31.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Jun 2025) to 31.00%, marking an increase of 4.00%.
- For Net Profit, as of Sep 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Jun 2025) to 55.00 Cr., marking a decrease of 12.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.31. The value appears to be declining and may need further review. It has decreased from 4.03 (Jun 2025) to 3.31, marking a decrease of 0.72.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,120 | 3,254 | 1,591 | 1,702 | 1,720 | 1,772 | 1,532 | 1,526 | 2,051 | 2,312 | 2,328 | 2,505 | 2,555 |
| Expenses | 2,908 | 3,031 | 1,386 | 1,492 | 1,502 | 1,539 | 1,342 | 1,385 | 1,882 | 2,109 | 2,023 | 2,192 | 2,226 |
| Operating Profit | 212 | 223 | 205 | 211 | 219 | 233 | 189 | 141 | 169 | 202 | 305 | 313 | 329 |
| OPM % | 7% | 7% | 13% | 12% | 13% | 13% | 12% | 9% | 8% | 9% | 13% | 12% | 13% |
| Other Income | 70 | 64 | 63 | 56 | 51 | 51 | 51 | 49 | 37 | 37 | 51 | 50 | 46 |
| Interest | 24 | 23 | 5 | 5 | 4 | 7 | 15 | 12 | 14 | 18 | 22 | 27 | 29 |
| Depreciation | 35 | 46 | 24 | 26 | 27 | 30 | 52 | 55 | 57 | 57 | 59 | 60 | 62 |
| Profit before tax | 222 | 218 | 240 | 236 | 238 | 247 | 173 | 123 | 136 | 164 | 274 | 276 | 285 |
| Tax % | 30% | 30% | 32% | 34% | 31% | 35% | 32% | 33% | 35% | 35% | 27% | 29% | |
| Net Profit | 156 | 152 | 164 | 155 | 165 | 197 | 155 | 115 | 134 | 168 | 236 | 259 | 258 |
| EPS in Rs | 9.09 | 8.89 | 9.58 | 9.05 | 9.66 | 11.65 | 9.43 | 7.04 | 8.05 | 10.05 | 14.02 | 15.55 | 15.50 |
| Dividend Payout % | 27% | 34% | 35% | 52% | 69% | 63% | 80% | 85% | 81% | 75% | 61% | 55% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2.56% | 7.89% | -5.49% | 6.45% | 19.39% | -21.32% | -25.81% | 16.52% | 25.37% | 40.48% | 9.75% |
| Change in YoY Net Profit Growth (%) | 0.00% | 10.46% | -13.38% | 11.94% | 12.94% | -40.71% | -4.49% | 42.33% | 8.85% | 15.10% | -30.73% |
Balmer Lawrie & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 10% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | 25% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:01 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 114 | 114 | 114 | 171 | 171 | 171 | 171 | 171 | 171 | 171 |
| Reserves | 953 | 1,015 | 1,210 | 1,247 | 1,342 | 1,406 | 1,383 | 1,371 | 1,416 | 1,510 | 1,650 | 1,798 | 1,773 |
| Borrowings | 175 | 197 | 0 | 0 | 15 | 81 | 120 | 125 | 122 | 121 | 113 | 106 | 237 |
| Other Liabilities | 724 | 670 | 559 | 669 | 720 | 682 | 660 | 712 | 736 | 860 | 939 | 966 | 1,049 |
| Total Liabilities | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 | 3,230 |
| Fixed Assets | 464 | 577 | 393 | 397 | 410 | 568 | 770 | 767 | 767 | 760 | 751 | 737 | 789 |
| CWIP | 77 | 12 | 11 | 63 | 138 | 117 | 24 | 32 | 11 | 28 | 52 | 67 | 79 |
| Investments | 0 | 0 | 248 | 271 | 293 | 325 | 375 | 386 | 436 | 518 | 565 | 632 | 669 |
| Other Assets | 1,339 | 1,322 | 1,146 | 1,299 | 1,350 | 1,272 | 1,165 | 1,194 | 1,231 | 1,356 | 1,505 | 1,604 | 1,693 |
| Total Assets | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 | 3,230 |
Below is a detailed analysis of the balance sheet data for Balmer Lawrie & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 171.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 171.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,798.00 Cr. (Mar 2025) to 1,773.00 Cr., marking a decrease of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 237.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 106.00 Cr. (Mar 2025) to 237.00 Cr., marking an increase of 131.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,049.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 966.00 Cr. (Mar 2025) to 1,049.00 Cr., marking an increase of 83.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,040.00 Cr. (Mar 2025) to 3,230.00 Cr., marking an increase of 190.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 789.00 Cr.. The value appears strong and on an upward trend. It has increased from 737.00 Cr. (Mar 2025) to 789.00 Cr., marking an increase of 52.00 Cr..
- For CWIP, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 669.00 Cr.. The value appears strong and on an upward trend. It has increased from 632.00 Cr. (Mar 2025) to 669.00 Cr., marking an increase of 37.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,693.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,604.00 Cr. (Mar 2025) to 1,693.00 Cr., marking an increase of 89.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,230.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,040.00 Cr. (Mar 2025) to 3,230.00 Cr., marking an increase of 190.00 Cr..
Notably, the Reserves (1,773.00 Cr.) exceed the Borrowings (237.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 37.00 | 26.00 | 205.00 | 211.00 | 204.00 | 152.00 | 69.00 | 16.00 | 47.00 | 81.00 | 192.00 | 207.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 53 | 53 | 60 | 57 | 57 | 65 | 69 | 56 | 57 | 67 | 70 |
| Inventory Days | 48 | 48 | 77 | 51 | 46 | 47 | 57 | 59 | 51 | 46 | 66 | 67 |
| Days Payable | 53 | 44 | 144 | 104 | 108 | 96 | 88 | 100 | 69 | 68 | 108 | 104 |
| Cash Conversion Cycle | 57 | 56 | -14 | 8 | -4 | 8 | 35 | 28 | 38 | 35 | 25 | 33 |
| Working Capital Days | 23 | 23 | -24 | 30 | 39 | 44 | 49 | 30 | 49 | 39 | 39 | 62 |
| ROCE % | 22% | 20% | 20% | 18% | 17% | 16% | 11% | 8% | 8% | 10% | 16% | 15% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 92,092 | 0.26 | 2.25 | 92,092 | 2025-04-22 17:25:41 | 0% |
| Groww Nifty Total Market Index Fund | 394 | 0.01 | 0.01 | 394 | 2025-04-22 17:25:41 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Diluted EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Cash EPS (Rs.) | 14.92 | 15.11 | 9.57 | 8.49 | 8.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Revenue From Operations / Share (Rs.) | 147.11 | 136.79 | 135.76 | 120.19 | 89.41 |
| PBDIT / Share (Rs.) | 21.20 | 20.80 | 13.98 | 12.06 | 11.09 |
| PBIT / Share (Rs.) | 17.68 | 17.34 | 10.66 | 8.79 | 7.88 |
| PBT / Share (Rs.) | 16.13 | 16.05 | 9.61 | 8.00 | 7.18 |
| Net Profit / Share (Rs.) | 11.39 | 11.65 | 6.25 | 5.23 | 4.83 |
| NP After MI And SOA / Share (Rs.) | 15.55 | 15.30 | 10.05 | 7.88 | 6.74 |
| PBDIT Margin (%) | 14.41 | 15.20 | 10.29 | 10.03 | 12.40 |
| PBIT Margin (%) | 12.01 | 12.67 | 7.85 | 7.31 | 8.80 |
| PBT Margin (%) | 10.96 | 11.73 | 7.07 | 6.65 | 8.03 |
| Net Profit Margin (%) | 7.74 | 8.52 | 4.60 | 4.35 | 5.40 |
| NP After MI And SOA Margin (%) | 10.57 | 11.18 | 7.40 | 6.55 | 7.54 |
| Return on Networth / Equity (%) | 13.50 | 14.36 | 10.22 | 8.48 | 7.47 |
| Return on Capital Employeed (%) | 12.90 | 13.71 | 9.02 | 7.83 | 7.27 |
| Return On Assets (%) | 8.74 | 9.10 | 6.45 | 5.50 | 4.84 |
| Long Term Debt / Equity (X) | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 |
| Total Debt / Equity (X) | 0.03 | 0.04 | 0.05 | 0.05 | 0.06 |
| Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.90 | 0.94 | 0.71 |
| Current Ratio (X) | 2.27 | 2.08 | 2.09 | 2.31 | 2.24 |
| Quick Ratio (X) | 1.99 | 1.81 | 1.77 | 1.93 | 1.94 |
| Inventory Turnover Ratio (X) | 13.04 | 5.07 | 7.88 | 5.34 | 3.90 |
| Dividend Payout Ratio (NP) (%) | 54.65 | 49.03 | 64.67 | 76.14 | 111.23 |
| Dividend Payout Ratio (CP) (%) | 44.55 | 39.98 | 48.61 | 53.84 | 75.30 |
| Earning Retention Ratio (%) | 45.35 | 50.97 | 35.33 | 23.86 | -11.23 |
| Cash Earning Retention Ratio (%) | 55.45 | 60.02 | 51.39 | 46.16 | 24.70 |
| Interest Coverage Ratio (X) | 13.67 | 16.13 | 13.33 | 15.17 | 15.92 |
| Interest Coverage Ratio (Post Tax) (X) | 8.34 | 10.04 | 6.96 | 7.58 | 7.93 |
| Enterprise Value (Cr.) | 2796.58 | 3661.98 | 1567.62 | 1642.42 | 1805.18 |
| EV / Net Operating Revenue (X) | 1.11 | 1.57 | 0.67 | 0.79 | 1.18 |
| EV / EBITDA (X) | 7.71 | 10.30 | 6.56 | 7.97 | 9.51 |
| MarketCap / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| Retention Ratios (%) | 45.34 | 50.96 | 35.32 | 23.85 | -11.23 |
| Price / BV (X) | 1.60 | 2.24 | 1.13 | 1.21 | 1.43 |
| Price / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| EarningsYield | 0.08 | 0.06 | 0.09 | 0.06 | 0.05 |
After reviewing the key financial ratios for Balmer Lawrie & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.92. This value is within the healthy range. It has decreased from 15.11 (Mar 24) to 14.92, marking a decrease of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 147.11. It has increased from 136.79 (Mar 24) to 147.11, marking an increase of 10.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.20. This value is within the healthy range. It has increased from 20.80 (Mar 24) to 21.20, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 17.34 (Mar 24) to 17.68, marking an increase of 0.34.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.13. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 16.13, marking an increase of 0.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.39. This value is within the healthy range. It has decreased from 11.65 (Mar 24) to 11.39, marking a decrease of 0.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For PBDIT Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.20 (Mar 24) to 14.41, marking a decrease of 0.79.
- For PBIT Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 12.01, marking a decrease of 0.66.
- For PBT Margin (%), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 10.96, marking a decrease of 0.77.
- For Net Profit Margin (%), as of Mar 25, the value is 7.74. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.74, marking a decrease of 0.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.57. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.57, marking a decrease of 0.61.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.50. This value is below the healthy minimum of 15. It has decreased from 14.36 (Mar 24) to 13.50, marking a decrease of 0.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.90. This value is within the healthy range. It has decreased from 13.71 (Mar 24) to 12.90, marking a decrease of 0.81.
- For Return On Assets (%), as of Mar 25, the value is 8.74. This value is within the healthy range. It has decreased from 9.10 (Mar 24) to 8.74, marking a decrease of 0.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has increased from 0.84 (Mar 24) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 2.08 (Mar 24) to 2.27, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 1.99, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.04. This value exceeds the healthy maximum of 8. It has increased from 5.07 (Mar 24) to 13.04, marking an increase of 7.97.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 54.65. This value exceeds the healthy maximum of 50. It has increased from 49.03 (Mar 24) to 54.65, marking an increase of 5.62.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 44.55. This value is within the healthy range. It has increased from 39.98 (Mar 24) to 44.55, marking an increase of 4.57.
- For Earning Retention Ratio (%), as of Mar 25, the value is 45.35. This value is within the healthy range. It has decreased from 50.97 (Mar 24) to 45.35, marking a decrease of 5.62.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 55.45. This value is within the healthy range. It has decreased from 60.02 (Mar 24) to 55.45, marking a decrease of 4.57.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 16.13 (Mar 24) to 13.67, marking a decrease of 2.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.34. This value is within the healthy range. It has decreased from 10.04 (Mar 24) to 8.34, marking a decrease of 1.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,796.58. It has decreased from 3,661.98 (Mar 24) to 2,796.58, marking a decrease of 865.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.11, marking a decrease of 0.46.
- For EV / EBITDA (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 7.71, marking a decrease of 2.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For Retention Ratios (%), as of Mar 25, the value is 45.34. This value is within the healthy range. It has decreased from 50.96 (Mar 24) to 45.34, marking a decrease of 5.62.
- For Price / BV (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 1.60, marking a decrease of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.08, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie & Company Ltd:
- Net Profit Margin: 7.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.9% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.5% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.4 (Industry average Stock P/E: 30.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Diversified | 21, Netaji Subhas Road, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Adhip Nath Palchaudhuri | Chairman & Managing Director |
| Mr. Saurav Dutta | Director - Finance & CFO |
| Dr. Vandana Minda Heda | Independent Director |
| Mr. Rajeev Kumar | Government Nominee Director |
| Mr. Raja Mani Uthayaraja | Director - Manufacturing Businesses |
| Mr. Abhijit Ghosh | Director - HR & Corporate Affairs |
| Mr. Romon Sebastian Louis | Director - Service Businesses |
| Mr. Harishkumar Madhusudan Joshi | Independent Director |
FAQ
What is the intrinsic value of Balmer Lawrie & Company Ltd?
Balmer Lawrie & Company Ltd's intrinsic value (as of 15 February 2026) is ₹173.89 which is 1.76% lower the current market price of ₹177.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,035 Cr. market cap, FY2025-2026 high/low of ₹238/147, reserves of ₹1,773 Cr, and liabilities of ₹3,230 Cr.
What is the Market Cap of Balmer Lawrie & Company Ltd?
The Market Cap of Balmer Lawrie & Company Ltd is 3,035 Cr..
What is the current Stock Price of Balmer Lawrie & Company Ltd as on 15 February 2026?
The current stock price of Balmer Lawrie & Company Ltd as on 15 February 2026 is ₹177.
What is the High / Low of Balmer Lawrie & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balmer Lawrie & Company Ltd stocks is ₹238/147.
What is the Stock P/E of Balmer Lawrie & Company Ltd?
The Stock P/E of Balmer Lawrie & Company Ltd is 11.4.
What is the Book Value of Balmer Lawrie & Company Ltd?
The Book Value of Balmer Lawrie & Company Ltd is 114.
What is the Dividend Yield of Balmer Lawrie & Company Ltd?
The Dividend Yield of Balmer Lawrie & Company Ltd is 4.79 %.
What is the ROCE of Balmer Lawrie & Company Ltd?
The ROCE of Balmer Lawrie & Company Ltd is 14.8 %.
What is the ROE of Balmer Lawrie & Company Ltd?
The ROE of Balmer Lawrie & Company Ltd is 14.0 %.
What is the Face Value of Balmer Lawrie & Company Ltd?
The Face Value of Balmer Lawrie & Company Ltd is 10.0.